Marion Baudard

1.7k total citations
34 papers, 1.3k citations indexed

About

Marion Baudard is a scholar working on Hematology, Molecular Biology and Oncology. According to data from OpenAlex, Marion Baudard has authored 34 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Hematology, 12 papers in Molecular Biology and 10 papers in Oncology. Recurrent topics in Marion Baudard's work include Acute Myeloid Leukemia Research (10 papers), Multiple Myeloma Research and Treatments (8 papers) and Immunotherapy and Immune Responses (8 papers). Marion Baudard is often cited by papers focused on Acute Myeloid Leukemia Research (10 papers), Multiple Myeloma Research and Treatments (8 papers) and Immunotherapy and Immune Responses (8 papers). Marion Baudard collaborates with scholars based in France, Germany and Switzerland. Marion Baudard's co-authors include R Zittoun, Bernard Klein, Ollivier Legrand, Jean‐Yves Perrot, Jean‐Pierre Marie, Ghislaine Simonin, F Viguié, M Cadiou, Jean‐François Rossi and Hartmut Goldschmidt and has published in prestigious journals such as Journal of Clinical Oncology, Blood and The Journal of Immunology.

In The Last Decade

Marion Baudard

33 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Marion Baudard France 18 686 541 369 312 191 34 1.3k
SM Watt United Kingdom 13 559 0.8× 394 0.7× 179 0.5× 369 1.2× 220 1.2× 20 1.1k
Shinichi Mizuno Japan 16 698 1.0× 1.0k 1.9× 405 1.1× 316 1.0× 141 0.7× 46 1.8k
NN Iscove Canada 16 724 1.1× 444 0.8× 313 0.8× 491 1.6× 52 0.3× 20 1.5k
M. Safford United States 10 688 1.0× 473 0.9× 267 0.7× 765 2.5× 97 0.5× 12 1.5k
Barbara Czepulkowski United Kingdom 19 789 1.2× 556 1.0× 241 0.7× 277 0.9× 232 1.2× 49 1.7k
Inger Marie S. Dahl Norway 20 1.1k 1.6× 696 1.3× 427 1.2× 108 0.3× 98 0.5× 37 1.7k
Yataro Yoshida Japan 18 664 1.0× 404 0.7× 177 0.5× 204 0.7× 114 0.6× 85 1.1k
Frédéric Barabé Canada 20 416 0.6× 732 1.4× 286 0.8× 348 1.1× 80 0.4× 38 1.3k
Sheila N.J. Sait United States 20 511 0.7× 510 0.9× 334 0.9× 86 0.3× 163 0.9× 72 1.2k
Yosuke Minami Japan 22 812 1.2× 802 1.5× 395 1.1× 287 0.9× 141 0.7× 103 1.6k

Countries citing papers authored by Marion Baudard

Since Specialization
Citations

This map shows the geographic impact of Marion Baudard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marion Baudard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marion Baudard more than expected).

Fields of papers citing papers by Marion Baudard

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marion Baudard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marion Baudard. The network helps show where Marion Baudard may publish in the future.

Co-authorship network of co-authors of Marion Baudard

This figure shows the co-authorship network connecting the top 25 collaborators of Marion Baudard. A scholar is included among the top collaborators of Marion Baudard based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marion Baudard. Marion Baudard is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Dummer, Reinhard, Stefan B. Eichmüller, Sylke Gellrich, et al.. (2010). Phase II Clinical Trial of Intratumoral Application of TG1042 (Adenovirus-interferon-γ) in Patients With Advanced Cutaneous T-cell Lymphomas and Multilesional Cutaneous B-cell Lymphomas. Molecular Therapy. 18(6). 1244–1247. 31 indexed citations
2.
Oudard, Stéphane, Olivier Rixe, Benoit Beuselinck, et al.. (2010). A phase II study of the cancer vaccine TG4010 alone and in combination with cytokines in patients with metastatic renal clear-cell carcinoma: clinical and immunological findings. Cancer Immunology Immunotherapy. 60(2). 261–271. 71 indexed citations
3.
Jourdan, Michel, Jérôme Moreaux, John De Vos, et al.. (2007). Targeting NF‐κB pathway with an IKK2 inhibitor induces inhibition of multiple myeloma cell growth. British Journal of Haematology. 138(2). 160–168. 44 indexed citations
4.
Condomines, Maud, Dirk Hose, P Raynaud, et al.. (2007). Cancer/Testis Genes in Multiple Myeloma: Expression Patterns and Prognosis Value Determined by Microarray Analysis. The Journal of Immunology. 178(5). 3307–3315. 96 indexed citations
6.
Condomines, Maud, Philippe Quittet, Zhao‐Yang Lu, et al.. (2006). Functional Regulatory T Cells Are Collected in Stem Cell Autografts by Mobilization with High-Dose Cyclophosphamide and Granulocyte Colony-Stimulating Factor. The Journal of Immunology. 176(11). 6631–6639. 47 indexed citations
7.
Mahtouk, Karène, Dirk Hose, Thierry Rème, et al.. (2005). Expression of EGF-family receptors and amphiregulin in multiple myeloma. Amphiregulin is a growth factor for myeloma cells. Oncogene. 24(21). 3512–3524. 80 indexed citations
9.
Viguié, F, Azzedine Aboura, Sylvie Ramond, et al.. (2000). Submicroscopic Insertion of RARα Gene into Chromosome 15 in Two Cases of Acute Promyelocytic Leukemia. Cancer Genetics and Cytogenetics. 119(2). 162–164. 11 indexed citations
10.
Legrand, Ollivier, Jean‐Yves Perrot, Marion Baudard, et al.. (2000). The immunophenotype of 177 adults with acute myeloid leukemia: proposal of a prognostic score. Blood. 96(3). 870–877. 116 indexed citations
11.
Legrand, Ollivier, Jean‐Yves Perrot, Marion Baudard, et al.. (2000). The immunophenotype of 177 adults with acute myeloid leukemia: proposal of a prognostic score. Blood. 96(3). 870–877. 14 indexed citations
13.
Baudard, Marion, et al.. (1998). Idiopathic thrombocytopenic purpura associated with Crohn's disease.. PubMed. 83(1). 92–3. 9 indexed citations
14.
Baudard, Marion, Alain Delmer, & R Zittoun. (1997). [Chronic myelomonocytic leukemia in adults].. PubMed. 45(7). 605–11.
15.
Baudard, Marion, Christian Pagnoux, Jean‐Noël Buy, et al.. (1997). Idiopathic Thrombocytopenic Purpura as the Presenting Feature of a Primary Bilateral Adrenal non Hodgkin's Lymphoma. Leukemia & lymphoma. 26(5-6). 609–613. 13 indexed citations
16.
Baudard, Marion, Ira Pastan, & M M Gottesman. (1996). Transfer of the MDR1 gene into haematopoietic cells. European Journal of Cancer. 32(6). 1019–1023. 2 indexed citations
17.
Lévy, Vincent, A. Bourgarit, Alain Delmer, et al.. (1996). Treatment of agnogenic myeloid metaplasia with danazol: A report of four cases. American Journal of Hematology. 53(4). 239–241. 26 indexed citations
18.
Baudard, Marion, J. P. Marie, M Cadiou, F Viguié, & R Zittoun. (1994). Acute myelogenous leukaemia in the elderly: retrospective study of 235 consecutive patients. British Journal of Haematology. 86(1). 82–91. 102 indexed citations
19.
Andreu, G., C Boccaccio, C Lecrubier, et al.. (1992). The Role of UV Radiation in the Prevention of Human Leukocyte Antigen Alloimmunization. Transfusion Medicine Reviews. 6(3). 212–224. 21 indexed citations
20.
Boccaccio, C, Isabel Garcı́a, Marion Baudard, et al.. (1990). Ultraviolet irradiation of platelet concentrates: In Vitro and In Vivo preclinical evaluation. Transfusion Science. 11(2). 141–147. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026